Pegtibatinase as a Treatment for Patients With Classical Homocystinuria (HCU) (Also Known as the COMPOSE Study)
Clinical trial NCT03406611 · RECRUITING
Trial details
- NCT number
- NCT03406611
- Sponsor
- Travere Therapeutics, Inc.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-22
- Primary completion
- 2027-07-01
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.